title: Ritonavir capsule manufacturing problems will require switch to liquid formulation.
authors.forename: J S
authors.initials: JS
authors.lastname: James
mesh_terms: D002214:Capsules; D004356:Drug Storage; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000600:supply & distribution; D006801:Humans; D019438:Ritonavir / Q000008:administration & dosage* / Q000600:supply & distribution; D012996:Solutions
chemical_list: D002214:Capsules; D017320:HIV Protease Inhibitors; D012996:Solutions; D019438:Ritonavir